KCP Statement on the Coronavirus Relief Package
A statement from John P. Butler, chair of Kidney Care Partners (KCP) and president & CEO of Akebia Therapeutics, regarding the coronavirus relief package: “Kidney Care Partners commends bipartisan members of Congress for recognizing the critical need to ensure that individuals living with kidney transplants can continue to access life-saving medications indefinitely to preserve their…
Kidney Community to Administration, Congress: Make Sure Vulnerable Patients Are Among the First in Line for COVID-19 Vaccine
CDC and Public Health Experts State that Patients with Kidney Disease Have Increased Risk of Severe COVID-19 Disease WASHINGTON, DC (November 25, 2020) – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers and manufacturers – today urged the Trump Administration…
The Kidney Community Advances Innovative Solutions and Improves Patient Care—Even During a National Pandemic Crisis
Authors from the American Society of Nephrology and Kidney Care Partners discuss the response of the kidney care community to the COVID-19 pandemic. As health professionals and medical researchers raced to understand the wide-reaching effects of coronavirus disease 2019 (COVID-19), kidney professionals have taken on more, transformed treatment, and made critical improvements to a system…
CMS Finalizes Kidney Care Model to Promote Home Dialysis, Live Donor Transplants
CMS today finalized a new payment model it said would give patients greater access to home dialysis and kidney transplants from live donors, which officials said would improve outcomes and quality of life while saving Medicare $23 million over 5 years. Trump administration officials said the model, which takes effect January 1, 2021, would be the…
CMS Moves to Boost Home Dialysis, Living Donor Kidney Transplants
Medicare beneficiaries with end-stage renal disease (ESRD) may soon have easier access to home dialysis and kidney transplants under a final rule issued Friday by the Centers for Medicare & Medicaid Services (CMS). “Today we’re announcing two major steps forward in our efforts to advance American kidney health,” Health and Human Services Secretary Alex Azar said Friday…
CMS To Start Mandatory ESRD Model In 2021 With 30% Of Providers
CMS on Friday (Sept. 18) announced it will start on Jan. 1 a mandatory demonstration aimed at increasing the use of home dialysis and kidney transplants — which the agency says should give providers plenty of time to prepare — and also revealed it will include 30% of dialysis facilities and providers managing adults with End-Stage Renal…
CMS finalizes ESRD Treatment Choices model, estimates $23 million in savings
CMS released the final version of its ESRD Treatment Choices payment model today, aimed at incentivizing dialysis providers to place more patients with end-stage renal disease on home dialysis or refer them for a kidney transplant. “President Trump is tackling a longstanding problem for people with kidney disease because they deserve better than a system…
CMS approves chronic kidney disease payment model
CMS on Friday unveiled its alternative payment model for patients with chronic kidney disease. The End-Stage Renal Disease ESRD Treatment Choices—ETC—model encourages increased home dialysis use and kidney transplants. According to the agency, it will affect nearly a third of kidney care providers and save the federal government about $23 million over five and a half years….
Statement by Kidney Care Partners on The ESRD Treatment Choices (ETC) Model
Kidney Care Partners (KCP) is carefully reviewing the release of the ESRD Treatment Choices Model today as a final rule, and we will provide a more detailed response following that review process. KCP thanks the Administration for its continued efforts to improve kidney care quality and care delivery to our nation’s most vulnerable Medicare population…
CMS Finalizes Models To Address Chronic Kidney Disease, Cancer
The Centers for Medicare & Medicaid Services (CMS) announced that two new care models to address chronic kidney disease and cancer were finalized Friday morning. The End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model aims to increase the usage of home dialysis and kidney transplants, with Medicare payments shifting from fee-for-service payments to value-based care…